Allergies including asthma and hay fever not linked to mental health traits
Allergic diseases such as asthma, atopic dermatitis and hay fever do not cause the onset of mental health conditions or vice versa, according to the findings of a new University of Bristol-led study published today (6 October) in the journal Clinical and Experimental Allergy. (Source: University of Bristol news)
Source: University of Bristol news - October 6, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Faculty of Life Sciences, Faculty of Life Sciences, School of Psychological Science; Press Release Source Type: news
What Causes Facial Pain?
Discussion
Dental caries are one of the most common infections. It is usually caused by Streptococcus viridans. Dental caries are also quite preventable with brushing the teeth at least twice a day with a fluoridated dentifrice, use of dental floss, and preventative dental appointments with application of fluoride varnish and sealants as appropriate. Fluoridated water supplies also help. A review can be found here.
Facial pain is often acute, self-limited and etiologies that may be obvious such as trauma or infection. Facial pain can also overlap with cranial pain (mainly headache), neck pain (often lymphadenopathy or musc...
Source: PediatricEducation.org - October 4, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Management of Pediatric Food Allergies Evolving Management of Pediatric Food Allergies Evolving
New focus emphasizes exposure to allergens rather than of blanket avoidance, although this approach may not always work in atopic dermatitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
This week's roundup on the region's life sciences industry includes one company securing two FDA approvals, a South Jersey institution receiving a $12 million research grant, and more. Here's the rundown:
Incyte Corp.
The Wilmington biotechnology company started the week receiving marketing clearance from the Food and Drug Administration for Opzelura, the company's topical cream for mild-to-moderate atopic dermatitis — a chronic skin disease that affects more than 21 million people in the Unit ed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2021 Category: Pharmaceuticals Authors: John George Source Type: news
FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis
The approval is for the treatment of non-immunocompromised patients aged 12 years and older with mild to moderate atopic dermatitis.FDA Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 22, 2021 Category: Internal Medicine Tags: Dermatology News Alert Source Type: news
